glp 1 neuroprotection GLP-1 Receptor Agonists Glucagon-like peptide-1 (GLP-1) receptor agonists

Date: January 23, 2026 Introduction In the high-stakes arena of metabolic medicine, few companies have generated as much speculative fervor and clinical awe as Viking Therapeutics (NASDAQ: VKTX)

Wainscott, Todd M

Available in two formulations, this allows for even greater personalization to help you reach your weight goals

Semaglutide slows gastric emptying , which prolongs the sensation of fullness after eating and contributes to reduced caloric intake

Binge eating, restriction, and emotional eating are rarely just about food

WASHINGTON On Thursday, the Food and Drug Administration (FDA) kicked off a two-day meeting to review the safety and efficacy of synthetic peptides